Resistance emergence to zidovudine (ZDV) and lamivudine (3TC(TM)) in HIV-1-infected patients in an ongoing open label trial

被引:0
|
作者
Rusconi, S [1 ]
dePasquale, MP [1 ]
Milazzo, L [1 ]
Moscatelli, G [1 ]
Kurtagic, S [1 ]
dArminioMonforte, A [1 ]
Galli, M [1 ]
机构
[1] UNIV MILAN,LUIGI SACCO HOSP,INFECT DIS UNIT,I-20122 MILAN,ITALY
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:P6 / P6
页数:1
相关论文
共 50 条
  • [1] Resistance to lamivudine (3TC) and zidovudine (ZDV) in a phase II comparative trial of 3TC vs ZDV vs 3TC plus ZDV
    Kuritzkes, DR
    Shugarts, D
    Griffin, A
    Bakhtiari, M
    Eron, J
    Quinn, J
    Fallon, MA
    Rubin, M
    Benoit, S
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 : 53 - 53
  • [2] Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients
    Kuritzkes, DR
    Quinn, JB
    Benoit, SL
    Shugarts, DL
    Griffin, A
    Bakhtiari, M
    Poticha, D
    Eron, JJ
    Fallon, MA
    Rubin, M
    [J]. AIDS, 1996, 10 (09) : 975 - 981
  • [3] Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy
    Kuritzkes, DR
    Shugarts, D
    Bakhtiari, M
    Poticha, D
    Johnson, J
    Rubin, M
    Gingeras, TR
    Kennedy, M
    Eron, JJ
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (01) : 26 - 34
  • [4] Acquisition of genotypic drug resistance in zidovudine (ZDV)-experienced patients receiving 3TC/ZDV combination therapy or ZDV monotherapy
    Kaye, S
    Loveday, C
    Comber, E
    Collis, P
    Tedder, RS
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 : 57 - 57
  • [5] A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients
    Ungsedhapand, C
    Kroon, EDMB
    Suwanagool, S
    Ruxrungtham, K
    Yimsuan, N
    Sonjai, A
    Ubolyam, S
    Buranapraditkun, S
    Tiengrim, S
    Pakker, N
    Kunanusont, C
    Lange, JMA
    Cooper, DA
    Phanuphak, P
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (02) : 116 - 123
  • [6] Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in the Gambia, West Africa
    Stewart B.
    Jobarteh M.L.
    Sarge-Njie R.
    Alabi A.
    De Silva T.
    Peterson K.
    Peterson I.
    Whittle H.
    Rowland-Jones S.
    Jaye A.
    Cotten M.
    Mendy M.
    [J]. BMC Research Notes, 4 (1)
  • [7] Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients
    Kost, RG
    Hurley, A
    Zhang, LQ
    Vesanen, M
    Talal, A
    Furlan, S
    Caldwell, P
    Johnson, J
    Smiley, L
    Ho, D
    Markowitz, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (04) : 332 - 339
  • [8] Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and Zidovudine (ZDV)
    Raise, E
    Guerra, L
    Viza, D
    Pizza, G
    DeVinci, C
    Schiattone, ML
    Rocaccio, L
    Cicognani, M
    Gritti, F
    [J]. BIOTHERAPY, 1996, 9 (1-3) : 49 - 54
  • [9] EMERGENCE AND CLINICAL RELEVANCE OF MUTATIONS ASSOCIATED WITH ZIDOVUDINE RESISTANCE IN ASYMPTOMATIC HIV-1-INFECTED PATIENTS
    CALDERON, EJ
    TORRES, Y
    MEDRANO, FJ
    LUQUE, F
    LARDER, B
    REY, C
    SANCHEZOUIJANO, A
    LISSEN, E
    LEAL, M
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (06) : 512 - 519
  • [10] A randomized, open-label, comparative trial of AZT/3TC versus AZT/3TC/ddI in antiretroviral naive HIV-1 infected Thai patients.
    Ungsedhapand, C
    Kroon, EDMB
    Suwannagool, S
    Ruxrungtham, K
    Newell, M
    Yinsuan, N
    Sonjai, A
    Ubolyam, S
    Weverling, GW
    Buranapraditkun, S
    Tiengrim, S
    Sirivichayakul, S
    Kunanusont, C
    Lange, JMA
    Cooper, DA
    Phanuphak, P
    [J]. AIDS, 1998, 12 : S96 - S96